IE 11 is a very old browser and is not supported on this site.

3. Operating segment information

Operating segment information first half of 2023

With the creation of the strategic partnership with Redcare Pharmacy N.V., the business unit Mediservice Ltd. (incl. Curarex Swiss Ltd.) which was part of the Products & Care segment, is presented as discontinued operations. Operating segment information for the previous period has been restated to conform to the new presentation and is line with the internal reporting. As a result, net sales to third parties has decreased by CHF 205.7 million and EBIT by CHF 5.0 million in 2022.  Further information of the discontinued operation can be found in note 4, Discontinued operations.

Operating segment information first half of 2023

in thousand CHF

Products & Care

Logistics & IT

Group Services

Eliminations

Galenica Group

Net sales

804,364

1,518,491

25,733

–497,398

1,851,190

Intersegmental net sales

–50,846

–423,283

–23,268

497,398

Net sales to third parties

753,518

1,095,208

2,464

1,851,190

Other income

3,387

3,995

1,971

–1,183

8,170

Share of profit from associates and joint ventures

2,812

8

128

2,948

Earnings before interest, taxes, depreciation and amortisation (EBITDA)

107,842

34,928

1,168

–38 1)

143,900

Depreciation, amortisation and impairment

–34,098

–15,869

–1,530

118

–51,379

Earnings before interest and taxes (EBIT)

73,744

19,058

–362

81 1)

92,521

Interest income

 

 

 

 

1,057

Interest expense

 

 

 

 

–3,564

Other net financial result

 

 

 

 

–471

Earnings before taxes (EBT)

 

 

 

 

89,543

Income taxes

 

 

 

 

–15,056

Profit from continuing operations

 

 

 

 

74,487

 

 

 

 

 

 

Assets

1,807,984

1,048,016

529,011

-576,067 2)

2,808,944

Investments in associates and joint ventures

138,486

91

–1,568

137,009

Liabilities

616,713

681,315

728,105

-546,118 3)

1,480,015

 

 

 

 

 

 

Investments in property, plant and equipment

11,552

5,418

1,669

18,639 4)

Investments in intangible assets

1,041

14,943

–37

15,947 5)

 

 

 

 

 

 

Employees as at 30 June (FTE)

4,081

1,445

232

5,758

1) Including the effects of IAS 19 from defined benefit plans and long-service awards of CHF 1.5 million

2) Of which elimination of intercompany positions of CHF -556.5 million and other unallocated amounts of CHF -19.5 million

3) Of which elimination of intercompany positions of CHF -556.5 million and other unallocated amounts of CHF 10.4 million

4) Of which non-cash investments of CHF 0.8 million

5) Of which non-cash investments of CHF 3.8 million

Operating segment information first half of 2022

Operating segment information first half of 2022 (restated)

in thousand CHF

Products & Care

Logistics & IT

Group Services

Eliminations

Galenica Group

Net sales

771,689

1,434,631

22,352

–474,464

1,754,208

Intersegmental net sales

–46,092

–407,347

–21,026

474,464

Net sales to third parties

725,598

1,027,284

1,326

1,754,208

Other income

3,992

2,962

1,438

–656

7,736

Share of profit from associates and joint ventures

1,937

20

62

2,019

Earnings before interest, taxes, depreciation and amortisation (EBITDA)

105,468

40,345

242

1,074 2)

147,129

Depreciation, amortisation and impairment

–32,951

–14,963

–1,062

147

–48,830

Earnings before interest and taxes (EBIT)

72,517

25,382

–820

1,221 2)

98,299

Interest income

 

 

 

 

387

Interest expense

 

 

 

 

–2,636

Other net financial result

 

 

 

 

–129

Earnings before taxes (EBT)

 

 

 

 

95,920

Income taxes

 

 

 

 

–16,922

Profit from continuing operations

 

 

 

 

78,998

 

 

 

 

 

 

Assets 1)

1,784,254

921,458

320,811

-413,699 3)

2,612,825

Investments in associates and joint ventures 1)

33,975

82

–1,375

32,682

Liabilities 1)

604,571

524,903

619,655

-385,765 4)

1,363,364

 

 

 

 

 

 

Investments in property, plant and equipment

4,125

13,400

1,127

18,652 5)

Investments in intangible assets

769

11,499

–70

12,198 6)

 

 

 

 

 

 

Employees as at 30 June (FTE)

3,831

1,377

216

5,424

1) Figures as at 31 December 2022

2) Including the effects of IAS 19 from defined benefit plans and long-service awards of CHF 1.4 million

3) Of which elimination of intercompany positions of CHF -395.6 million and other unallocated amounts of CHF -18.1 million

4) Of which elimination of intercompany positions of CHF -395.6 million and other unallocated amounts of CHF 9.8 million

5) Of which non-cash investments of CHF 0.9 million

6) Of which non-cash investments of CHF 1.8 million

Galenica verwendet Cookies, um die Funktionen der Website zu optimieren und Ihnen das bestmögliche Erlebnis zu gewährleisten. Gebrauch von Cookies & Disclaimer